There is a great demand for appropriate alternative methods to rapidly evaluate the developmental and reproductive toxicity of a wide variety of chemicals. We used the differentiation of mouse embryonic stem cells (mESCs) into cardiomyocytes as a basis for establishing a rapid and highly reproducible in vitro embryotoxicity test known as the Hand1-Luc Embryonic Stem Cell Test (Hand1-Luc EST). In this study, we developed novel neural-Luc ESTs using two marker genes for neural development, tubulin beta-3 (Tubb3) and Reelin (Reln), and evaluated the capacity of these tests to predict developmental toxicity. In addition, we tested whether an integrated approach (a combination of neural-Luc ESTs and the Hand1-Luc EST) improved developmental toxicant detection. To perform our neural-Luc ESTs, we needed to generate stable transgenic mESCs with individual promoters linked to the luciferase gene, and to establish that similar changes in promoter activities and mRNA expression levels occur during neural differentiation. Based on the concentration-response curves of 15 developmental toxicants and 17 non-developmental toxic chemicals, we derived a prediction formula and assessed the capacity of this formula to predict developmental toxicity. Although both were highly sensitive and specific for predicting developmental toxicity, neural-Luc ESTs had similar predictive capacities. In contrast, neural-Luc ESTs and Hand1-Luc EST had significantly different predictive powers. As expected, the combination of these ESTs increased the sensitivity of developmental toxicant detection. These results demonstrate the convenience and the usefulness of this combination of ESTs as an alternative assay system for future toxicological and mechanistic studies of developmental toxicity.
In our society, consumers are more and more intensively exposed to chemicals produced by the industry. The different possible toxicities triggered by those compounds need to be accurately tested before putting chemicals on the market. To reduce animal use and accelerate toxicity testing, numerous in vitro alternative test methods have been proposed. An established in vitro test for embryotoxicity is the embryonic stem cell test (EST), which assesses the embryotoxic effect of chemicals based on the differentiation of mouse embryonic stem cell (mESCs) into cardiomyocytes (Genschow et al., 2002) . A previous study of the European Framework Programme 7 project ChemScreen included this established EST as an apical assay. As developmental toxicity is associated with a multitude of developmental processes and mechanisms, recent studies have attempted to combine several in vitro assays to form test battery (Kroese et al., 2015; Piersma et al., 2013) . In addition, other test strategies have been suggested such as those involving neural and osteoblast differentiation, or employing both molecular techniques along with embryotoxicological methods (Theunissen et al., 2012) .
To rapidly and reliably predict embryotoxicity, there is an urgent need for a short-duration, high-throughput model. One option would be a test based on the differentiation of mESCs into neuronal-type as well as myocardial-type cells. Comprehensive and comparative gene expression pattern analyses of mESC differentiation into myocardial and neural cells disclosed a large number of genes that are responsive to embryotoxic substances (Rempel et al., 2015; Suzuki et al., 2011a; Theunissen et al., 2013) . Although combining myocardial with neural differentiation models can improve the predictive accuracy of embryotoxicity testing, the properties of few genes have been exploited in highthroughput in vitro assay development.
We have previously explored the gene expression profiles of mESCs exposed to embryotoxic chemicals during differentiation into myocardial cells by DNA chip and quantitative PCR; identified heart and neural crest derivatives expressing transcript 1 (Hand1) as a novel marker of the impact of hazardous chemicals on myocardial cell differentiation, and developed a highthroughput EST (Hand1-Luc EST) using the Hand1 promoter linked upstream of luciferase reporter gene in stable transgenic mESCs (Le Coz et al., 2015; Suzuki et al., 2011a,b) . Extensive investigation of Hand1-Luc EST was performed to examine reproducibility by comparing a set of six well-known test chemicals across the laboratories. The results showed good correspondence in all four laboratories, indicating that the established technical protocols of Hand1-Luc EST are transferable, intraand inter-laboratory reproducible (Suzuki et al., 2012) . Following those results, the Hand1-Luc EST undertook an international validation study from Feb. 2013 until Feb. 2016 . It is now under peer review so as to bring the protocol to an Organization for Economic Co-operation and Development (OECD) test guideline.
Hand1 plays a key role on the cardiac differentiation process, and is also involved in cranial morphogenesis and limbs formation (Firulli et al., 2014; Laurie et al., 2016; Reamon-Buettner et al., 2009) . Thus, the embryotoxicants that do not affect directly or indirectly on Hand1 gene expression might not be detected in the Hand1-Luc EST, suggesting that Hand1-Luc EST has limitations and that no conclusion can be drawn if a negative result is triggered in the test. To improve the test, we recently showed that adding solubility of chemicals in medium and metabolic stability tests to the Hand1-Luc EST raised the accuracy of its embryotoxicity prediction (Nagahori et al., 2016) . Li et al. also demonstrated the usefulness of the classical EST in combination with the in vitro placental permeability test to predict the in vivo developmental toxicity potencies of chemicals (Li et al., 2016) .
We have previously shown that the expression of reelin (Reln) was specifically and significantly decreased by embryotoxicant treatment during mESCs differentiation into neural cells (Suzuki et al., 2011a) . Reelin is a neuronal glycoprotein secreted by Cajal-Retzius cells in the marginal zone of the cerebral cortex and hippocampus where it plays critical roles in the control of neuronal migration and the formation of cellular layers during brain development (Ranaivoson et al., 2016) . On the other hand, tubulin is the major constituent of microtubules, and the well-known neural differentiation marker tubulin beta-3 (Tubb3) plays a pivotal role in proper axon guidance and maintenance (Hayess et al., 2013) . As immature neuron differentiation and migration are steps in central nervous system development, we focused our investigation on Reln and Tubb3. In this study, we established stable transgenic mESC lines containing a construct of Reln or Tubb3 promoter linked to the luciferase reporter gene; designed a neural-Luc EST protocol using these stable transformants; configured the protocol for multi-well plate formats, and performed these ESTs to detect chemical embryotoxicity. In addition, we examined whether performance of the neural-Luc ESTs could increase the capacity of Hand1-Luc EST to predict the embryotoxic potential of chemical substances.
MATERIALS AND METHODS
Test chemicals. Embryotoxic and non-embryotoxic chemicals used in this study and their references of retrieved articles are shown in Tables 1 and 2 , respectively. The purity of all chemicals tested was > 98.0%.
Construction of plasmids.
The 5-kb sequence of the Reln promoter and 2-kb sequence of the Tubb3 promoter were amplified from genomic DNA of mESCs using primers (5 0 -GGGCATT CTCTCACATGGTT-3 0 and 5 0 -GCGCTCTCTCATCCACTTTC-3 0 ) and
Each DNA fragment was inserted into the KpnI and EcoRI sites of the pGL4.17 luciferase vector (Promega, Madison, Wisconsin), respectively.
Establishment of stable transgenic mESCs. The stable transgenic mESCs with Tubb3 or Reln promoter upstream of luciferase reporter gene were established as previously described (Le Coz et al., 2015) . Briefly, the linearized plasmid was transfected into mESCs (KOB1) using lipofectamine 2000 (Thermo Fisher Scientific, Waltham, Massachusetts) in accordance with the manufacturer's protocol. The transfected cells were dissociated into single cells, seeded onto the feeder cells, and selected with 100 lg/ml of G418 (Nacalai Tesque, Osaka, Japan). The isolated stable transgenic mESCs clones (Tubb3-Luc/mESCs and RelnLuc/mESCs) were cryopreserved in CELLBANKER (Nippon Zenyaku Kogyo, Fukushima, Japan) before use.
Cell viability and luciferase assays. The cell viability and luciferase activity were determined by non-lytic CellTiter Fluor Cell Viability Assay (Promega) and Steady-Glo Luciferase Assay (Promega), respectively. Cytotoxicity was expressed as the concentration of chemical that reduced the viability of cells to 50% of the control level (IC 50 ). The differentiation toxicity was expressed as the concentration of chemical that reduced the luciferase activity to 50% of the control level (ID 50 ).
PCR and real-time RT-PCR assay. Genomic DNA in mESCs was extracted using DNAeasy Blood & Tissue kit (Qiagen, Hilden, Germany) in accordance with the manufacturer's instructions. Genomic PCR was performed using primers spanning the promoter and luciferase gene. Primers used for Tubb3-Luc/mESCs and Reln-Luc/mESCs were (5 0 -TATAATCCGCCACCGTCCTG-3 0 and 5 0 -CCGAACGCTCATCTCGAAGT-3 0 ) and (5 0 -CCTCGGTCTCCC GCTAACTT-3 0 and 5 0 -CCCGTCTTCGAGTGGGTAGA-3 0 ), respectively. Total RNA was extracted using the RNeasy Micro Kit (Qiagen, Hilden, Germany) in accordance with the manufacturer's protocol. Expression of mouse Reln and Tubb3 was quantified using TaqMan probes (Applied Biosystems, Foster City, California), Mm00465200_m1* and Mm00727586_s1*, respectively. The relative expression level was normalized against that of the HPRT gene in the same RNA preparation.
Neural differentiation of mESCs. Stable transgenic mESCs were maintained in Glasgow's MEM (G-MEM; Thermo Fisher Scientific) supplemented with 10% KnockOut Serum Replacement (KSR; Thermo Fisher Scientific), 1% FBS, 0.1 mM non-essential amino acids, 1 mM sodium pyruvate, and 0.1 mM 2-mercaptoethanol (2-ME) on murine embryonic fibroblast (MEF) feeder cells (ReproCELL, Yokohama, Japan) in the presence of 2 U/ml leukemia inhibitory factor (LIF; Oriental Yeast, Tokyo, Japan). For neural differentiation, cells were cultured in differentiation medium (G-MEM supplemented with 10% KSR, 2 mM L-glutamine, 1 mM sodium pyruvate, 0.1 mM nonessential amino acids, 0.1 mM 2-ME, and 1 lM SB431542) in Nunclon sphera 96U plates (Thermo Fisher Scientific) for 144 h, which was changed to DMEM/F12 with GlutaMax and N2 supplement (WAKO Pure Chemical, Osaka, Japan) and replaced twice a week.
Hand1-Luc EST assay. The general protocol for the Hand1-Luc EST was previously described (Le Coz et al., 2015) . Briefly, Hand1-Luc/mESCs in DMEM supplemented with 15% FBS, 2 mM L-glutamine, 1% non-essential amino acids, and 0.1 mM 2-ME were seeded onto white, round bottom, low attachment 96-well culture plates (MS-9096W; Sumitomo Bakelite, Tokyo, Japan). Cells were treated with chemicals for 120 h, and then their viability and luciferase activity were determined.
Neural-Luc EST assays. After being seeded onto the MS-9096W plate in differentiation medium, Tubb3-Luc/mESCs or Reln-Luc/ mESCs were exposed to chemicals for 144 h without changing medium, and then their viability and luciferase activity were determined.
Determination of maximum dissolvable dose. The maximum dissolvable dose (MD) was determined as previously described (Nagahori et al., 2016) . It is defined as the highest attainable concentration of chemical that dissolves in the medium used in the Hand1-Luc EST assay. The maximum final concentrations in the culture medium of Phosphate Buffered Saline (PBS (-)) and DMSO were 1% (v/v) and 0.1% (v/v), respectively. The test chemicals were first dissolved in PBS (-) to obtain 100 mg/ml (MD ¼ 1.0 mg/ml). If the chemical was not soluble in PBS (-) at 100 mg/ml, it was diluted 2-or 4-fold to completely dissolve in Nuclear receptor activation PBS (-) at 50 or 25 mg/ml, respectively (MD ¼ 0.5 or 0.25 mg/ml, respectively). If the chemical was not soluble in PBS (-) at 25 mg/ ml, it was dissolved in DMSO at 1000 mg/ml, and the precipitation test was performed by addition of the chemical dissolved in DMSO to the medium. In case it was soluble in the medium, the MD value of chemical was 1.0 mg/ml. If the chemical dissolved in DMSO was not soluble in the medium, the highest soluble concentration was determined by diluting the solution from 500 mg/ml at a common ratio of two with DMSO, and the precipitation test was performed. The solvent used to dissolve the test chemicals are shown in Tables 1 and 2 .
Data analysis. The activity of each test chemical was calculated relative to that of the vehicle control (100%). The concentrationresponse data were fitted to three-parameter sigmoid functions and the resulting curves were used to determine the IC 50 and ID 50 (Nagahori et al., 2016) . The three-parametric logistic function for the i-th concentration X i and the i-th observed mean value Z i was Zi ¼ c expða þ bXiÞ 1 þ expða þ bXiÞ a, b, and c were fitted values by iteration method using the least square method. IC 50 and ID 50 are calculated by common ratio to the power of a/b. The above fitting method allowed implementation of the automatic calculation function in Excel (Microsoft) and an Excel spreadsheet was developed to fit the curve and to estimate the IC 50 and ID 50 .
Immunohistochemistry. Cryosections of mESCs were immunostained with mouse anti-nestin monoclonal antibody (BD Biosciences, San Jose, California) or mouse anti-troponin monoclonal antibody (Abcam, Cambridge, Massachusetts). Localization of antigens was visualized using appropriate secondary antibodies (Alexa Fluor 594 or 488; Molecular Probes, Eugene, Oregon).
Statistical analysis. Linear discriminant analysis with leave-oneout cross-validation and receiver operating characteristic (ROC) analysis were carried out for 32 test chemicals (15 developmental toxicants and 17 non-developmental toxicants) using PASW Statistics (SPSS Inc, Chicago, Illinois). The common logarithms of IC 50 /ID 50 and MD/IC 50 were selected as dimensionless descriptors and used in discriminant analysis.
RESULTS

Characterization of Stable Transgenic mESCs
After transfecting mESCs (KOB1) with plasmids carrying Tubb3 or Reln promoter driving luciferase reporter gene, single clone resistant to G418 were selected and named as Tubb3-Luc/ mESCs or Reln-Luc/mESCs, respectively. Genomic PCR analysis of drug-resistant cells using primers spanning the promoter and luciferase confirmed cells carrying a transgene ( Figure 1A ). Bright-field microscopy showed no difference in gross morphology of stable transgenic mESCs clones compared with untransfected ones ( Figure 1B ). To examine the effects of a transgene on pluripotency of mESCs, cells were differentiated into neural or myocardial cells. As shown in Figure 1C , expression of neural marker Nestin was observed in stable transgenic mESCs as well as un-transfected ones under the neural differentiation condition. In addition, the stable transgenic mESCs expressed myocardial marker Troponin demonstrated by immunohistochemistry ( Figure 1C ) and real-time RT-PCR assay (data not shown) under the myocardial differentiation condition. These results suggested that both stable transgenic mESCs maintain pluripotency. To assess the stability of transgene expression, stable transgenic mESCs were serially passaged, incubated for 144 h under the neural differentiation condition, and the activity of luciferase was determined. As shown in Figure 1D , the luciferase activity remained relatively unchanged until passage (P)-7. Thus, we confirmed the stability of the transfect within the cells which have been stored in liquid nitrogen at earlier passages of three and used until P7.
Neural Cell Marker Expression in Stable Transgenic mESCs
Activin, a member of the transforming growth factor-beta (TGFb) superfamily, exhibits various roles during different stages of embryogenesis. SB431542, a blocker of TGF-b type I receptor, has been shown to enhance the neural differentiation of mESCs (Matulka et al., 2013) . To examine whether a blockage of TGF-b/ activin signaling increases the gene expressions of Tubb3 and Reln in the stable transgenic mESCs, we used the luciferase assay and real-time RT-PCR assay to determine promoter activity and mRNA expression level, respectively. As shown in Figure 2A , treatment of Tubb3-Luc/mESCs with SB431542 stimulated the Tubb3 promoter activity in parallel with its gene expression. Consistent with previous findings (Schulpen et al., 2015) , the time-dependent elevations in both promoter activity and mRNA expression of Reln were similar with those of Tubb3 during neural differentiation ( Figure 2B ). These results suggested that the time-dependent changes in Tubb3 and Reln promoter activity were closely connected with those of Tubb3 and Reln mRNA expression, and that the expression profiles of Tubb3 and Reln genes were similar in mESCs undergoing neural differentiation.
Predictive Performance of the Test for Neural Differentiation Toxicity
The results described above indicate that the luciferase activity (as a relevant, sensitive, and convenient measure of gene expression level) can be exploited to estimate the effects of chemicals on the differentiation of mESCs into neural cells. To build a high-throughput screening system of ESTs, we first determined the optimal cell density and the timing of test chemical addition. Tubb3-Luc/mESCs were seeded into 96-well microplates at 3, 6, or 9 Â 10 3 /well and several concentrations of papaverine, which is a developmental neurotoxicant (Table 1) , were added 2 h after seeding. After incubation for 144 h under the neural differentiation condition, cell viability and luciferase activity were measured, and the IC 50 and ID 50 values were calculated from concentration-response curves generated from cell viability and luciferase activity data measured in the same well, respectively. Although both activities of untreated mESCs were elevated with increasing numbers of cells, the ratio of IC 50 to ID 50 was highest when cells were seeded at 6 Â 10 3 /well (Supplementary Figure   1A) . Next, Tubb3-Luc/mESCs were seeded at 6 Â 10 3 /well, and were exposed to papaverine 2, 24 or 96 h after seeding and incubated until 144 h. As a result, the magnitude of differences between the IC 50 and ID 50 values were the highest when the cells were treated with the chemical 2 h after seeding (Supplementary Figure 1B) . Finally, we confirmed the reproducibility of these ESTs using another developmental toxicant, 5-fluorouracil (5-FU). Based on four independent experiments, we found that these methods provide reproducible with low variation (CV < 25%) means to detect hazardous chemicals ( Supplementary Figures 2 and 3) .
For the established neural-Luc ESTs, the stable transgenic mESCs (6 Â 10 3 /well), Tubb3-or Reln-Luc/mESCs, were treated 2 h after seeding with various concentrations of chemicals the highest one being MD. As solubility of chemicals in the culture medium is a crucial factor in EST (Genschow et al., 2002) , we introduced the concept of using MD values to predict toxicity. After 144 h of incubation with chemicals under the neural differentiation condition, the IC 50 and ID 50 values were calculated from concentration-response curves generated from cell viability and luciferase activity data measured in the same well, respectively ( Figure 3 ). The variety of chemicals, the concentration unit and data analysis were the same as the Hand1-Luc EST we have already established. To validate and compare the ability of neural-Luc ESTs to correctly predict developmental toxicity of chemicals, we exposed stable transgenic mESCs to a wide range of Reln-Luc/mESCs Tubb3-Luc/mESCs (Tables 3 and 4 ). Although some curves had a V shape leading to truncated IC 50 and ID 50 values, the curves were better adjusted with a two-parameter curve fitting to avoid this case. This fitting also erases the problem of curve rising from the concentration 0 and then falling along with the increasing concentration of chemicals ( Figure 4B , retinoic acid; Supplementary Figure 4 , VPA). On the other hand, there were some cases where IC 50 remained lower than the ID 50 value, which were improved by implementing a three-parameter curve fitting instead of a twoparameter curve fitting method (Supplementary Figure 4 , methylmercury). Accordingly, the concentration-response data were fitted to three-parameter sigmoid functions and the resulting curves were used to determine the IC 50 and ID 50 (Nagahori et al., 2016) . The linear discriminant analysis with the full dataset and the cross validation were conducted to develop a model that discriminates positive from negative in vivo developmental toxicants using the descriptors MD/IC 50 and IC 50 /ID 50 because a large gap between MD and IC 50 , and/or between IC 50 and ID 50 has high chances to trigger a positive result (Nagahori et al., 2016) . The best cut-off points were determined by ROC analysis (0.42 and 0.41 for Tubb3-Luc EST and Reln-Luc EST, respectively). As a result, we obtained the following predictive equations: logit (probability) ¼ 2.318 Â log(IC 50 /ID 50 )þ0.741 Â log(MD/ IC 50 )À1.091 (probability ! 0.42; predicted as an embryotoxicant in the Tubb3-Luc EST) and logit (probability) ¼ 1.112 Â log(IC 50 / ID 50 )þ0.928 Â log(MD/IC 50 ) À0.822 (probability ! 0.41; predicted as an embryotoxicant in the Reln-Luc EST) (data not shown). The probability was calculated by the equation and the classification as positive or negative neural differentiation toxicant was determined by applying cut-off values (Tables 3 and 4 ). In the Tubb3-Luc EST, the test chemicals producing positive or negative in vivo outcomes were correctly predicted with 73% sensitivity, 71% specificity, and 72% accuracy (Table 5) . On the other hand, in the Reln-Luc EST, both sensitivity and negative predictive values were 80% and the overall accuracy was 75% (Table 5) . Taken together, these results suggested that the ability of these ESTs to predict developmental toxicity is highly sensitive and specific, but similar.
Comparison of the Predictive Ability Between Neural-Luc ESTs and
Hand1-Luc EST ESCs can differentiate into cell types of all three primary germ layers and chemical substances can have deleterious effects on ESCs, causing developmental toxicity. Focusing on the differentiation of mESCs into myocardial cells, we have established a rapid and highly reproducible in vitro test for embryotoxicity, the Hand1-Luc EST (Le Coz et al., 2015; Suzuki et al., 2011b) . We next compared the ability to predict developmental toxicity between neural-Luc ESTs and the Hand1-Luc EST. Boric acid, an ingredient of many cosmetics, pharmaceuticals, and pesticides, has been tested for developmental toxicity in timed-pregnant animals. One of the most frequently observed malformations in the fetal rats were enlarged lateral ventricles of the brain (Heindel et al., 1992) . As shown in Figure 4A , exposure of stable transgenic mESCs to boric acid increased cytotoxicity and differentiation toxicity in a concentration-dependent manner; however, the calculated ID 50 values in Tubb3-and Reln-Luc/mESCs (31.90 and 38.93 lg/ml, respectively) were low compared with the corresponding IC 50 values (61.51 and 166.40 lg/ml, respectively), suggesting that the inhibitory effects of boric acid on neural differentiation of mESCs were not due to cytotoxicity. In contrast, the changes of both cell viability and luciferase activity were almost the same in Hand1-Luc/mESCs ( Figure 4A ). These results suggested that boric acid may be specifically inhibiting neural differentiation. Retinoic acid had previously been reported to promote stem cell neural lineage specification and neuron differentiation (Kawasaki et al., 2000) , but to abrogate cardiac development (Engberg et al., 2010) . In contrast, it is well known that administration of retinoic acid produces embryofetal developmental toxicity in various laboratory animals (Table  1) . Our results showed that retinoic acid treatment suppresses luciferase activities in both Tubb3-Luc/mESCs and Hand1-Luc/ mESCs in a concentration-dependent manner at a much lower concentration than the MD, suggesting that retinoic acid may be a general embryotoxicant ( Figure 4B and Table 3 ). Collectively, these results indicate that the stable transgenic mESCs with respective differentiation marker genes respond properly to developmental toxic chemicals.
To investigate the effects of chemicals on myocardial and neural differentiation of mESCs, the ID 50 values of all test chemicals were compared. As shown in Figure 5A , ID 50 values were strongly correlated between Tubb3-Luc/mESCs and Reln-Luc/ mESCs (R 2 ¼ 0.85). In contrast, ID 50 values were only weakly correlated between Tubb3-Luc/mESCs and Hand1-Luc/mESCs ( Figure 5B ), and between Reln-Luc/mESC and Hand1-Luc/mESCs ( Figure 5C ), suggesting that the combination of two neuron lineage markers could broaden the range of hazardous chemical detection insofar as substances may act through different toxicological mechanisms during differentiation of mESCs. We next explored the possibility that combining neural with myocardial differentiation toxicity tests might improve predictive performance. The method to calculate IC 50 and ID 50 values from Hand1-Luc EST data was the same as that to calculate these values from neural-Luc ESTs data, and the equation to estimate the probability of myocardial differentiation toxicity was: logit (probability) ¼ 1.474 Â log(IC 50 /ID 50 )þ0.714 Â log(MD/ IC 50 ) À1.109 (probability ! 0.52; predicted as an embryotoxicant in Hand1-Luc EST) (Nagahori et al., 2016 values of all test chemicals were plotted against probabilities obtained from the predictive equation, and a threshold was applied. As expected, two (penicillamine and phenytoin) out of four hazardous chemicals, which were predicted to be non-embryotoxicants in the Tubb3-Luc EST, were identified as embryotoxicants in the Hand1-Luc EST ( Figure 6A ). Phenytoin was also predicted to be a non-embryotoxicant in the Reln-Luc EST but was identified as an embryotoxicant in the Hand1-Luc EST ( Figure 6B ). On the other hand, three developmental toxicants (methylazoxymethanol acetate [MAM] , boric acid, and lithium chloride [LiCl] ) were predicted to be non-embryotoxicants in the Hand1-Luc EST, but properly identified as embryotoxicants in the neural-Luc ESTs (Figs. 6A and B) . These results suggested that the combination of neural-Luc ESTs and the Hand1-Luc EST increases the sensitivity of developmental toxicant detection. However, the combination of ESTs using the stable transgenic mESCs was unable to classify warfarin as an embryotoxicant (Figs. 6A and B) . On the other hand, almost all test chemicals exhibited the same predictive results in the two neural-Luc ESTs ( Figure 6C ). In contrast, the ID 50 /IC 50 value could not distinguish embryotoxicants from nonembryotoxicants (Tables 3 and 4) .
DISCUSSION
When chemical production levels are high, REACH legislation mandates developmental and reproductive toxicity testing for chemical safety evaluation in Europe, and these tests account for an estimated 65% of all animal use and are very costly and labor intensive (Schulpen et al., 2015) . To supplement or even replace animal use, the alternative test methods have been developed. Thus, it is reasonable to expect that the results of alternative assays using animal cells could be linked with in vivo data. ESCs, which have the ability to differentiate into a wide range of cell types, have been used to establish efficient predictive alternative test methods for the embryotoxicity. The ESTs using mouse or human ESCs (hESCs) are currently in wide use for assessing the embryotoxic potential of chemicals (Yu et al., 2015) . Future studies to compare the results obtained from in vitro tests using mESCs and hESCs are required to predict the developmental toxicity of chemical substances in human. Finding a new strategic approach using in vitro assays as a general screening tool followed by a confirmatory in vivo study might be the best way to proceed for this sensitive aspect of human safety, at least until more data emerge to show the safest way to replace animals with more in vitro systems (van der Laan et al., 2012) . In addition, ESCs derived from other animals could provide important insights into the species differences in the embryotoxic potential of chemicals.
Comprehensive and comparative analyses showed that gene expression responds to embryotoxicity, but failed to find the specific genes responsive to embryotoxic chemicals in the respective mESC differentiation lineages (Rempel et al., 2015; Theunissen et al., 2013) . We have previously identified Hand1 and Reln as specific markers whose expression is attenuated by embryotoxicants during differentiation of mESCs into myocardial and neural cells, respectively (Suzuki et al., 2011a) . The Hand1-Luc EST is a promising alternative method for evaluating embryotoxicity; however, its predictive ability can be improved. In striving to refine the Hand1-Luc EST, we have recently demonstrated that the addition of metabolic stability test enhances the sensitivity of embryotoxicant testing (Nagahori et al., 2016) .
Li et al. also demonstrated the usefulness of the classical EST in combination with the in vitro placental permeability test to predict the in vivo developmental toxicity potencies of chemicals (Li et al., 2016) . Our study was undertaken to investigate whether the inclusion of the neural-Luc ESTs using mESCs in a testing strategy could result in enhanced predictive power as compared with the Hand1-Luc EST only. We first established novel highthroughput ESTs that utilize mESCs differentiating into neurons by measuring the expressions of Tubb3 and Reln. The validation experiment using 15 embryotoxicants and 17 non-embryotoxic chemicals suggested that the neural-Luc ESTs could be suitable for predicting developmental toxicity of chemicals. In addition, we demonstrated that combination of the Hand1-Luc EST and neural-Luc ESTs enhanced the sensitivity of embryotoxicant detection. Our alternative assay system would greatly assist the detection of deleterious chemicals. The Adverse Outcome Pathway (AOP) concept has recently been proposed to support a paradigm shift in regulatory toxicology testing and risk assessment. Although a battery of complementary tests generally reduces the specificity of toxicant detection, future developments in integrated approaches to testing and assessment based on the AOP could overcome this issue.
Morphological monitoring in addition to quantitative analyses has identified Tubb3 as one of the most promising neural differentiation specific markers. The extracellular matrix protein, reelin, a 440-kDa secreted glycoprotein, controls radial migration and layer formation of cortical neurons, in part by modulation of cytoskeletal dynamics and microtubule assembly (Meseke et al., 2013) . The cytoskeleton is composed of three distinct elements: actin microfilaments, microtubules, and intermediate filaments. Cytoskeletal elements must be coordinately regulated for the cell to fulfill complex cellular functions such as migration, adhesion and cell division. Gene expression analysis in mESCs revealed the very similar patterns of Tubb3 and Reln gene expression during neural differentiation (Figure 2 between Tubb3-Luc/mESCs and Reln-Luc/mESCs ( Figure 5) . Furthermore, the sensitivity of developmental toxicant detection by the combined Reln-Luc EST and Hand1-Luc EST was comparable to that by the Tubb3-Luc EST plus Hand1-Luc EST ( Figure 6 ). These results suggest that the molecular pathway of gene expression resulting neural cell migration appears to be controlled in a coordinated manner. In contrast, the prediction of embryotoxicity was similar but not identical between neuralLuc ESTs (Table 2) , and the Reln-Luc EST compared with the Tubb3-Luc EST had greater predictive power (Table 5) . Thus, we cannot exclude the possibility that the same signal transduction pathway regulates both Tubb3 and Reln gene transcription. In conclusion, our results suggest that Tubb3-Luc EST and RelnLuc EST could equally enhance the ability of the Hand1-Luc EST to broadly detect embryotoxicity. Further validation studies may shed light on the differences between EST batteries. Detection of differentiation blockade in ESCs by in vitro assays allows the selection of chemical series with minimal toxicity at the early phase of drug discovery. As the undifferentiated ESCs are characterized by nearly unlimited self-renewal capacity and have been shown to differentiate into cells of all three primary germ layers, it is a reasonable expectation that a battery of embryotoxicity tests focusing on the distinct differentiation lineages increase the ability to discriminate between embryotoxic and non-embryotoxic chemicals. As shown in Supplementary Figure 6 , mESCs were originally taken from blastocytes $3.5 days old, the experimental period in this study is from E3.5 to E8.5 days and to E9.5 days in vivo for the Hand1-Luc EST and the neural-Luc ESTs, respectively. The heart and the neural tube begin to form during this time window (Emouse Atlas Project). Furthermore, the period covered by the ESTs we are proposing is situated before and after the gastrulation. Thus, chemicals having an effect before the gastrulation period would affect the three germ layer and its teratogenicity potential would be detectable by all the EST (Hand1, Tubb3 and Reln). However, a chemical that would affect only one layer, for example the ectoderm, would be only detectable by Reln and Tubb3 ESTs but not in the Hand1 EST which is situated in the mesoderm. This is why a battery test of ESTs covering the three germ layers is required to be able to predict with a higher accuracy developmental toxicity of chemicals in vitro. With this model in mind, as expected, two in vivo embryotoxicants, penicillamine and phenytoin, which were predicted to be nonembryotoxic by the Tubb3-Luc EST, were successfully recognized as embryotoxic by the Hand1-Luc EST. Previous studies showed that these two embryotoxicants have the potential to inhibit embryonic heart cell differentiation (Ahir and Pratten, 2014; Groebe et al., 2010b) . On the other hand, MAM, boric acid, and LiCl, which were predicted to be non-embryotoxicants by the Hand1-Luc EST, were correctly classified as embryotoxicants by the neural-Luc ESTs. Prenatal exposure of pregnant rats to MAM on embryonic day 15 produces hippocampal malformation and laminar disorganization of the cerebral cortex (Imai et al., 2012) . When tested for developmental toxicity in mice and rats, boric acid (an ingredient of cosmetics, pharmaceuticals, and pesticides) was observed to cause brain malformations, most frequently enlarged lateral ventricles (Heindel et al., 1992) . In addition, LiCl has been suggested to influence neuronal differentiation (Schmidt et al., 2001) . Overall, the neurotoxicants were properly classified as embryotoxicants by the neural-Luc ESTs, and the myocardial toxicants were successfully detected as embryotoxic chemicals by the Hand1-Luc EST (Tables 1 and 3; Figure 6 ). Collectively, these findings suggest that the combination of neural-Luc ESTs and Hand1-Luc EST increases the sensitivity of developmental toxicant detection. Adjusting the timing and dose of a test chemical under the undifferentiation or differentiation conditions could assess its potential as a general embryotoxicant or an organ specificembryotoxicant such as a developmental neurotoxicant (Hayess et al., 2013) .
In contrast, the EST battery identified warfarin as a negative embryotoxicant. Although the teratogenic effects of warfarin have been reported in humans, warfarin exhibited no developmental toxicity in rats, mice, and rabbits (Riebeling et al., 2012) . The inability of neural-Luc ESTs or Hand1-Luc EST using the stable transgenic mESCs to predict the embryotoxicity of warfarin may be explained by the species difference in embryotoxic susceptibility. Further studies using a variety of ESCs including hESCs could shed light on the elucidation of species differences in the embryotoxic potential of chemicals. In addition, as the developmental process is complex and involves hundreds of signaling pathways, all of these mechanisms of development and toxicity may not readily be mimicked in vitro (van der Laan et al., 2012) . Inclusion of another complementary assay to the testing strategy might improve its predictive power.
In summary, we developed novel high-throughput neuralLuc ESTs and demonstrated their potential utility as alternative methods for assessing developmental and reproductive toxicity. In addition, we demonstrated that neural-Luc ESTs combined with the Hand1-Luc EST broadens the range of developmental toxicant detection. Our alternative assay systems provide a novel insight into the potential mechanism of action triggered by short-term exposure to developmental toxins.
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